Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
1421602-69-8
278803-20-6
370864-63-4
1247626-90-9 | (1-propionyl-3-pyrrolidinyl)methanol | AA01FM4X | MFCD16714480
1497207-17-6 | 3-(1H-imidazol-1-yl)cyclohexan-1-amine | AA01FMA0 | MFCD23734648
1820615-29-9 | 5-(Methoxymethyl)isoxazol-3-amine hydrochloride | AA01FMD0 | MFCD29037867
1435804-43-5 | 2-Amino-N-(2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethyl)acetamide hydrochloride | AA01FMGL | MFCD23136109
893723-53-0 | 3-Bromo-1,8-naphthyridine-2-carboxylic acid | AA01FMKL | MFCD06254347
1820666-71-4 | 8-Bromo-n,n-dimethyl-1,2,3,4-tetrahydro-1,6-naphthyridin-5-amine | AA01FMOR | MFCD28369850
872696-04-3 | 2-Hydrazino-6-isopropyl-1,3-benzothiazole | AA01FMXD | MFCD17178526
1351644-36-4 | Ethyl 2-(2-imino-6-sulfamoylbenzo[d]thiazol-3(2h)-yl)acetate hydrobromide | AA01FN0U | MFCD22587721
64261-07-0 | Benzoic acid, 4-[[[4-(dimethylamino)phenyl]methyl]amino]-, ethyl ester | AA01FNFY | MFCD00032375
1809063-96-4 | (2-((hexylamino)methyl)phenyl)boronic acid | AA01FNTH | MFCD32206257
804433-45-2
70403-69-9
1357784-62-3
315710-31-7
Journal: Bioorganic & medicinal chemistry letters20101101